rna therapy clinical trial intelligence

Efficacy of Working Memory Maintenance Mechanisms in Alzheimer's Disease and Vascular Dementia

Efficacy of Working Memory Maintenance Mechanisms in Alzheimer's Disease and Vascular Dementia is a registry-stage clinical asset sponsored by University Hospital, Grenoble in Alzheimer Disease, Vascular Dementia, Mixed Dementias. SEO and diligence focus: Complex span task, Clinical neuropsychological assessment, Clinical neurospychological assessement, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Immunogenicity of a Third Dose of mRNA-1273 Vaccine (Moderna) Among Cancer Patients

Immunogenicity of a Third Dose of mRNA-1273 Vaccine (Moderna) Among Cancer Patients is a registry-stage clinical asset sponsored by H. Lee Moffitt Cancer Center and Research Institute in Covid19, SARS-CoV2 Infection. SEO and diligence focus: mRNA-1273, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Expression of D2-Like Dopamine Receptor of Human Aldosterone-Producing Adenoma and Its Role in Regulation of Aldosterone Secretion and Cell Proliferation

Expression of D2-Like Dopamine Receptor of Human Aldosterone-Producing Adenoma and Its Role in Regulation of Aldosterone Secretion and Cell Proliferation is a registry-stage clinical asset sponsored by National Taiwan University Hospital in Hypertension, Adrenal Aldosterone-Producing Adenoma. SEO and diligence focus: mRNA, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Transcriptome, Proteome and Microbiome Profile in Periodontal and Peri-implant Diseases

Transcriptome, Proteome and Microbiome Profile in Periodontal and Peri-implant Diseases is a registry-stage clinical asset sponsored by Karolinska Institutet in Peri-implantitis, Periodontitis. SEO and diligence focus: Periodontitis and Peri-implantitis, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Biomarker Signatures of the Sleep-pain Enigma; a Collaborative Health Initiative Research Program (CHIRP) Funded Project

Biomarker Signatures of the Sleep-pain Enigma; a Collaborative Health Initiative Research Program (CHIRP) Funded Project is a registry-stage clinical asset sponsored by Defense and Veterans Center for Integrative Pain Management in Post Surgical Pain and Sleep Impairment. SEO and diligence focus: mRNA, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Psychological Assessment of Scoliosis Patients Undergoing Surgical Management (PASS)

Psychological Assessment of Scoliosis Patients Undergoing Surgical Management (PASS) is a NA clinical asset sponsored by Montefiore Medical Center in Adolescent Idiopathic Scoliosis (AIS), Mental Health. SEO and diligence focus: Aims to Decrease Anxiety and Pain Treatment (ADAPT), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Recurrent GBM Stem Cell Tumor Amplified RNA Immunotherapy Trial

Recurrent GBM Stem Cell Tumor Amplified RNA Immunotherapy Trial is a PHASE1 clinical asset sponsored by John Sampson in Recurrent Central Nervous System Neoplasm. SEO and diligence focus: BTSC mRNA-loaded DCs, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Preoperative Predictors of Weight Loss and Improved Metabolic Health After Bariatric Surgery

Preoperative Predictors of Weight Loss and Improved Metabolic Health After Bariatric Surgery is a registry-stage clinical asset sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) in Obesity, Morbid, Insulin Sensitivity, Bariatric Surgery Candidate, Feeding Behavior. SEO and diligence focus: mRNA, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma

Monitoring SARS-CoV-2 Vaccines and COVID-19 Related Outcomes in Individuals With Multiple Myeloma is a registry-stage clinical asset sponsored by ASH Research Collaborative in Multiple Myeloma. SEO and diligence focus: Patient Reported Outcomes, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Mitophagic Flux and Mitochondrial DNA Dynamics During Circadian-Aligned Ramadan Dry Fasting Versus 16:8 Time-Restricted Feeding: A Four-Phase Translational Research Programme

Mitophagic Flux and Mitochondrial DNA Dynamics During Circadian-Aligned Ramadan Dry Fasting Versus 16:8 Time-Restricted Feeding: A Four-Phase Translational Research Programme is a registry-stage clinical asset sponsored by Bahcesehir Cyprus University in Mitochondrial Degradation, Autophagy, Fasting, Healthy Volunteers, Metabolic Adaptation. SEO and diligence focus: Ramadan Intermittent Dry Fasting (Sawm), 16:8 Time-Restricted Feeding (TRF), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients

The EUropean TRAnsplantation and INnovation Consortium for Risk Stratification in Kidney Transplant Patients is a registry-stage clinical asset sponsored by Assistance Publique - Hôpitaux de Paris in Kidney Transplant Rejection, Kidney Transplantation, Risk Stratification, Prognosis. SEO and diligence focus: kidney transplantation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Therapeutic Efficacy and Feasibility Study of Abbott's BurstDR Spinal Cord Stimulators Technology for Painful Diabetic Neuropathy (PDN)

Therapeutic Efficacy and Feasibility Study of Abbott's BurstDR Spinal Cord Stimulators Technology for Painful Diabetic Neuropathy (PDN) is a NA clinical asset sponsored by TriCity Research Center in Painful Diabetic Neuropathy (PDN), Diabetic Neuropathy, Neuropathic Pain, Chronic Pain. SEO and diligence focus: BurstDR Spinal Cord Stimulation, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

"Effect of Supervised Resistance Training on Arm Volume and Quality of Life amONG Women at High Risk for Breast Cancer-related Lymphedema: a Study Protocol for a Randomized Controlled Trial (STRONG-B)"

"Effect of Supervised Resistance Training on Arm Volume and Quality of Life amONG Women at High Risk for Breast Cancer-related Lymphedema: a Study Protocol for a Randomized Controlled Trial (STRONG-B)" is a NA clinical asset sponsored by Pontificia Universidad Catolica de Chile in Breast Cancer, Physical Activity, Lymphedema of Upper Arm. SEO and diligence focus: Resistance Training, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster in Healthy Adults

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of the Bio-Manguinhos/Fiocruz COVID-19 (mRNA) Vaccine Booster in Healthy Adults is a PHASE1 clinical asset sponsored by The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) in Severe Acute Respiratory Syndrome (SARS-CoV-2 Virus). SEO and diligence focus: Grupo 1 - dose 25 μg, Group 2 - 50 μg dose, Group 3 - 100 μg, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Biomarkers in Thyroid Cancer

Biomarkers in Thyroid Cancer is a registry-stage clinical asset sponsored by Norman Eberhardt in Cancer of the Thyroid, Neoplasms, Thyroid, Thyroid Adenoma, Thyroid Cancer, Thyroid Carcinoma. SEO and diligence focus: mRNA, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.

Matched by modality_normalized: RNA therapy

Investigation of Inflammation Induced by Obstructive Sleep Apnea: Effects of Continuous Positive Airway Pressure (CPAP), Massive Weight Loss and the Bioactive Compound Resveratrol

The study, sponsored by the University of Aarhus, aimed to investigate the metabolic changes induced by OSA and the effects of massive weight loss post-bariatric surgery on inflammation and insulin sensitivity. Given the high prevalence of OSA among obese individuals and its association with significant comorbidities, the findings could have substantial implications for the development of therapeutic strategies targeting inflammation and metabolic disorders. The market for obesity-related treatments, including bariatric surgery and associated metabolic therapies, is considerable, with ongoing demand for effective interventions. The discontinuation of the resveratrol and CPAP components may limit the study's broader applicability but allows for a focused analysis of weight loss effects, which is a critical area of interest in obesity management.

The Salivary Microbiome in Children With Type 1 Diabetes Mellitus

The study conducted by Hadassah Medical Organization aims to elucidate the differences in the salivary microbiome between children with Type 1 Diabetes Mellitus (T1DM) and healthy controls. This research could have significant implications for understanding the oral health challenges faced by diabetic children, potentially leading to new diagnostic tools or therapeutic strategies. The market for diabetes management and related oral health products is substantial, with increasing awareness of the microbiome's role in health. Competitively, this study may position Hadassah as a leader in microbiome research related to diabetes, attracting partnerships or funding opportunities. Diligence implications include the need for further studies to validate findings and explore commercial applications.

Matched by modality_normalized: RNA therapy

Perturbation of Interactome Through Micro-RNA And Methylome Analyses In Diabetes Endophenotypes: the PIRAMIDE Study Design

The PIRAMIDE study, led by Giuditta Benincasa at the University of Campania Luigi Vanvitelli, aims to elucidate the interplay between DNA methylation and microRNA in T2D and its cardiovascular complications. Given the rising prevalence of T2D globally, understanding these molecular interactions could lead to novel prognostic biomarkers and therapeutic targets, enhancing the competitive landscape in diabetes management. The study's findings may provide insights that could be leveraged for developing epigenetic-based interventions or diagnostics, potentially positioning the sponsor favorably in the growing diabetes and cardiovascular disease markets.

Matched by modality_normalized: RNA therapy

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Immunogenicity of SARS-CoV-2 mRNA Vaccine (LVRNA009) in Chinese People Aged 18 Years and Over

AIM Vaccine Co., Ltd. is conducting a Phase I clinical trial of the mRNA vaccine LVRNA009 targeting the SARS-CoV-2 virus in the Chinese population aged 18 years and older. The trial aims to assess safety, tolerability, and preliminary immunogenicity. Given the ongoing global demand for effective COVID-19 vaccines, this asset has potential commercial value, particularly in the Chinese market where vaccination efforts continue. The competitive landscape includes established players like Pfizer-BioNTech and Moderna, which may pose challenges in market penetration. Diligence is warranted to evaluate the trial's progress and any emerging data that could influence market positioning.

Matched by modality_normalized: RNA therapy

The Effect of ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and Insulin Secretion in a MODY-2 Family

The study focuses on the role of glucokinase mutations in MODY-2 diabetes, a rare genetic form of diabetes that affects insulin secretion and glucose metabolism. Given the increasing prevalence of diabetes globally, insights from this study could lead to novel therapeutic strategies targeting glucokinase pathways. The findings may enhance understanding of diabetes mechanisms, potentially influencing drug development in the diabetes market. Competitive implications include the potential for new diagnostics or therapeutics that could differentiate from existing diabetes treatments, particularly for genetically defined patient populations. Diligence considerations should include assessing the commercial viability of targeting glucokinase mutations and the potential for partnerships with genetic testing companies.

Matched by modality_normalized: RNA therapy

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

The QuantifyHER study, sponsored by the Abramson Cancer Center at Penn Medicine, aims to evaluate a quantitative HER2 assay for its ability to predict treatment response in patients with HER2-low metastatic breast cancer receiving T-DXd (Enhertu). This study targets a niche yet significant segment of the breast cancer market, particularly focusing on patients with HER2 IHC 1+ expression. The findings could enhance the precision of HER2-targeted therapies, potentially leading to improved patient outcomes and positioning the sponsor favorably in the competitive landscape of breast cancer therapeutics. The study's collaboration with Danaher Inc. may also indicate a strategic partnership for diagnostic development, which could further strengthen market positioning.

Matched by modality_normalized: RNA therapy

Immunogenicity Induced by COVID-19 Vaccines in Mexican Population: mRNA Expression for IgG Anti-spike

This observational study, sponsored by the National Polytechnic Institute in Mexico, aimed to assess the immunogenicity of four COVID-19 vaccines (Oxford/AstraZeneca, Sputnik V, Pfizer/BioNTech, and Sinovac) in the Mexican population. The findings could provide valuable insights into the comparative effectiveness of these vaccines, potentially influencing public health policies and vaccine distribution strategies in Mexico and similar markets. Given the ongoing global focus on COVID-19 vaccination and booster strategies, the results may also have implications for future vaccine development and market positioning. The completion of this study suggests readiness for data dissemination, which could attract interest from pharmaceutical companies and public health organizations looking to enhance vaccine efficacy and safety profiles.

Matched by modality_normalized: RNA therapy

Effect of Cryopreservation on SARS-CoV-2 Semen Samples: Influence of Two Different Cryopreservation Procedures Evaluated After Thawing

The study conducted by Istituto Clinico Humanitas addresses a critical gap in understanding the impact of SARS-CoV-2 on male reproductive health, particularly in the context of cryopreservation of semen. Given the increasing focus on fertility preservation amid the pandemic, this research could lead to the development of new protocols for semen cryopreservation that mitigate viral contamination risks. The findings may have significant implications for reproductive medicine and fertility clinics, potentially enhancing market offerings in fertility preservation services. Furthermore, the results could inform regulatory considerations and guidelines for handling biological samples in the context of viral infections, impacting competitive positioning in the reproductive health sector.

Matched by modality_normalized: RNA therapy

Long-term Outcomes of Myocarditis Following Administration of SPIKEVAX (COVID-19 Vaccine mRNA)

The ongoing observational study sponsored by ModernaTX, Inc. aims to assess the long-term outcomes of myocarditis following administration of the SPIKEVAX COVID-19 vaccine. Given the increasing scrutiny of vaccine safety, particularly concerning myocarditis, the results of this study could significantly impact public perception, regulatory scrutiny, and future vaccine uptake. The study's findings may also influence Moderna's market position against competitors, particularly in the context of emerging vaccines and therapies for COVID-19 and related conditions. Furthermore, the data could be pivotal for Moderna in addressing safety concerns and enhancing its product portfolio.

Matched by modality_normalized: RNA therapy

A Phase 1, Observer-Blind, Randomized, Controlled Study to Evaluate the Safety and Immunogenicity of an Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

GlaxoSmithKline's investigational mRNA seasonal flu/COVID-19 combination vaccine is positioned to address the dual threat of seasonal influenza and COVID-19, particularly in the vulnerable older adult population (ages 65-85). The market for combination vaccines is growing, driven by the increasing demand for efficient immunization strategies amid ongoing pandemic concerns. This asset could enhance GSK's portfolio in the vaccine space, especially as public health strategies evolve towards combination vaccines to simplify immunization schedules. Competitive implications include potential advantages over single-target vaccines, particularly if safety and efficacy are demonstrated. Diligence considerations should focus on regulatory pathways, market access strategies, and potential partnerships for distribution.

Matched by modality_normalized: RNA therapy

A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705

ModernaTX, Inc. is advancing mRNA-3705, an innovative mRNA therapy targeting isolated methylmalonic acidemia (MMA) due to MUT deficiency. This Phase 1/2 extension study aims to assess the long-term safety and clinical activity of mRNA-3705 in patients previously enrolled in earlier trials. The global market for MMA therapies is limited, presenting a niche opportunity for mRNA-3705. However, the competitive landscape includes traditional enzyme replacement therapies and emerging gene therapies. Successful outcomes could position Moderna favorably within this specialized market, particularly if mRNA-3705 demonstrates superior efficacy or safety compared to existing treatments. Diligence should focus on regulatory pathways, reimbursement strategies, and potential partnerships for market access.

Matched by modality_normalized: RNA therapy

An Exploratory Basket Study on The Application of Therapeutic mRNA Vaccine Targeting FAP in Advanced Malignant Solid Tumors

The exploratory basket study sponsored by West China Hospital aims to evaluate the safety and efficacy of a therapeutic mRNA vaccine targeting FAP in combination with immune checkpoint inhibitors for patients with advanced malignant solid tumors. Given the increasing interest in mRNA-based therapies and the critical role of CAFs in tumor progression, this trial could position the sponsor favorably within the oncology market. The potential to enhance the efficacy of existing immunotherapies by targeting the tumor microenvironment may provide a competitive edge against other therapies that do not address CAFs. However, the trial is not yet recruiting, and the timeline for results will be crucial for market positioning and investor interest.

Matched by modality_normalized: RNA therapy

Exercise-induced Changes in Exosomes

The study conducted by the University of California, Davis, explores the role of exercise-induced exosomal changes in enhancing connective tissue properties, specifically focusing on engineered ligaments. This research could have significant implications for the development of regenerative therapies and sports medicine products aimed at improving ligament repair and function. The findings may position the sponsor favorably within the growing market for tissue engineering and regenerative medicine, particularly as interest in non-invasive and biologically-based treatments increases. Competitively, this study addresses a notable gap in understanding muscle-connective tissue interactions, potentially leading to novel therapeutic strategies that could outperform existing treatments. Diligence implications include the need to assess the commercial viability of any resultant therapies and the potential for partnerships with biotech firms specializing in regenerative medicine.

Matched by modality_normalized: RNA therapy

Sepsis Multiomic Analysis & Risk sTratification in China (China SMART-1): A Prospective Observational Cohort Study

The China SMART-1 study, sponsored by Yuebei People's Hospital, aims to address critical gaps in sepsis diagnosis and management by developing a comprehensive multi-omics biobank. With an estimated 240 cases of sepsis per 100,000 population in China and a high mortality rate of 35.5% in ICU patients, the demand for effective diagnostic tools is substantial. The study's focus on early detection and risk stratification could position it favorably within a growing market for sepsis diagnostics, which is increasingly shifting towards personalized medicine. The outcomes may lead to novel diagnostic products that could enhance patient outcomes and reduce healthcare costs. Competitive implications include potential partnerships with diagnostic companies and the need for diligence on existing patents related to multi-omics approaches in sepsis.

Matched by modality_normalized: RNA therapy

ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib and New Relevant Therapeutic Targets in Refractory Patients

The study conducted by Centre Antoine Lacassagne aims to identify predictive markers of resistance to sunitinib in mRCC patients, focusing on ELR+CXCL cytokines as potential therapeutic targets. Given the high unmet need for effective treatments in mRCC, the identification of these biomarkers could lead to improved patient stratification and treatment personalization, enhancing market opportunities for diagnostics and targeted therapies. The competitive landscape includes existing anti-angiogenic therapies and emerging immunotherapies. Companies developing companion diagnostics for mRCC may find strategic partnerships or acquisition opportunities in this space, particularly if the findings validate the clinical utility of ELR+CXCL cytokines.

Matched by modality_normalized: RNA therapy

"High Levels of EMT-TFs for the Diagnosis of Colorectal Cancer (CRC)"

The study sponsored by Istituto Clinico Humanitas aims to develop a diagnostic assay based on the detection of EMT-TFs mRNA levels in blood samples from colorectal cancer (CRC) patients. This approach could enhance early diagnosis, disease progression monitoring, and recurrence risk assessment, potentially positioning the assay as a valuable tool in the liquid biopsy market. Given the increasing focus on non-invasive diagnostic methods, this study may attract interest from pharmaceutical companies and diagnostic firms looking to expand their oncology portfolios. Competitive implications include the need to assess existing liquid biopsy technologies and their efficacy in CRC diagnosis, as well as the potential for partnerships or acquisitions in the biomarker space.

Matched by modality_normalized: RNA therapy

Active Aging: Effect of Life-long Endurance Exercises on the Circadian Regulation of Physiological Processes and Their Maintenance in Aging

The study sponsored by Comenius University aims to elucidate the effects of lifelong endurance exercise on various health parameters in aging populations. Given the increasing global focus on healthy aging and the prevention of age-related diseases, the findings could have significant implications for the development of exercise-based interventions or therapies. The market for aging-related health solutions is expanding, with a growing demand for evidence-based approaches to enhance quality of life in older adults. Competitive analysis suggests that while there are existing studies on exercise and aging, this research addresses gaps in understanding the specific impacts of endurance training on circadian rhythms and metabolic health, potentially positioning it as a unique offering in the wellness and geriatric health sectors.

Matched by modality_normalized: RNA therapy

Evaluating the Effectiveness of the LiveSpo® Preg-Mom and LiveSpo® KIDS Spore Probiotics in Supporting the Reduction of Constipation, Anorexia, and Slow Weight Gain in Children Aged 24-60 Months

Anabio R&D's clinical trial evaluates the effectiveness of LiveSpo® Preg-Mom and LiveSpo® KIDS spore probiotics in addressing common pediatric health issues such as constipation, anorexia, and slow weight gain in children aged 24-60 months. Given the rising prevalence of these conditions in Asia, particularly Vietnam, the market potential for effective probiotic solutions is significant. The trial's completion and positive outcomes could position Anabio R&D favorably within the growing probiotics market, which is increasingly recognized for its role in gut health and overall well-being. Competitive analysis suggests that while there are existing probiotic products, the specific focus on spore-forming probiotics targeting pediatric populations may provide a unique selling proposition. Diligence implications include the need for robust post-trial marketing strategies and potential partnerships with healthcare providers to facilitate product adoption.

A Comparison of p53-induced Genes Activation as Possible Markers Differentiating Between Patients Presenting With Acute Myocardial Infarction and Controls

The study conducted by Meir Medical Center aimed to explore p53-induced gene activation as potential biomarkers for differentiating between patients with acute myocardial infarction (AMI) and controls. Given the limitations of current biomarkers like troponin, which are not effective in early diagnosis and can yield false positives, the findings could position p53-related biomarkers as a novel diagnostic tool in the cardiology market. If validated, this could lead to significant commercial opportunities in the diagnostics sector, particularly in acute care settings. The competitive landscape includes existing cardiac biomarkers, but a successful outcome could provide a unique value proposition. Diligence should focus on the reproducibility of results and the regulatory pathway for any new diagnostic tests developed from this research.

Matched by modality_normalized: RNA therapy

A Phase II Randomised, Open-label Study of Gemcitabine/Carboplatin First-line Chemotherapy in Combination With or Without the Antisense Oligonucleotide Apatorsen (OGX-427) in Advanced Squamous Cell Lung Cancers

The ongoing Phase II trial investigates the efficacy of Apatorsen (OGX-427), an antisense oligonucleotide targeting Hsp27, in combination with standard chemotherapy (gemcitabine/carboplatin) for patients with advanced squamous cell lung cancer (NSCLC). Given the limited treatment options for this patient population, successful outcomes could position Apatorsen as a novel therapeutic option, potentially enhancing the effectiveness of existing chemotherapy regimens. The market for lung cancer treatments is substantial, with increasing demand for innovative therapies. Competitive analysis indicates that while several therapies are available, few specifically target Hsp27, suggesting a unique market position if clinical efficacy is demonstrated. Diligence should focus on the trial's recruitment status, safety profile, and competitive landscape, particularly regarding other emerging therapies targeting similar pathways.

Role of Novel Urinary Genomic and Metablomic Markers in Diagnosis of Bladder Cancer in Patients With Hematuria

The Xpert Bladder Cancer Monitor (Xpert Monitor) represents a promising non-invasive diagnostic tool for bladder cancer, targeting patients with hematuria. Given the increasing incidence of bladder cancer and the limitations of current diagnostic methods, this assay could capture significant market share, particularly in regions with high rates of hematuria. The competitive landscape includes traditional cytology and cystoscopy, which are more invasive and less patient-friendly. The successful completion of this trial indicates potential for commercialization, pending further validation and regulatory approval. Additionally, the focus on non-invasive diagnostics aligns with current trends towards patient-centric healthcare solutions.

Matched by modality_normalized: RNA therapy

Impact of the Immune System on Response to COVID-19 Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

The study, sponsored by the University of Liege, aims to evaluate the immune response to the BNT162b2 (Comirnaty®) COVID-19 vaccine in allogeneic stem cell transplant recipients. Given the unique patient population and the urgent need for effective vaccination strategies in immunocompromised individuals, the results could inform clinical guidelines and enhance vaccine uptake in this demographic. The collaboration with Pfizer suggests potential for further partnership opportunities, particularly in expanding the understanding of vaccine efficacy in vulnerable populations. The findings may also influence market positioning for COVID-19 vaccines and related therapies, especially as booster strategies evolve.

Matched by modality_normalized: RNA therapy

A Phase I/II, Open Label, Single Arm, Multicenter Study of LioCyx in Subjects With Recurrent Hepatitis B Virus-Related Hepatocellular Carcinoma Post Liver Transplantation

Lion TCR Pte. Ltd. is investigating LioCyx, an autologous T cell therapy targeting HBV-related hepatocellular carcinoma (HCC) in post-liver transplantation patients. Given the high recurrence rates of HCC in this population, LioCyx addresses a significant unmet medical need, particularly in Asian markets where HBV is prevalent. The competitive landscape includes traditional therapies and emerging immunotherapies, but LioCyx's unique mechanism may provide a differentiated approach. However, the trial's withdrawal due to manufacturing changes raises concerns regarding the product's development timeline and regulatory pathway, necessitating diligence on manufacturing capabilities and timelines for resubmission.

Matched by modality_normalized: RNA therapy

Timing To Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy For Rectal Cancer: A Multicenter Randomized Controlled Trial - Biomarkers SubStudy

The TiMiSNAR-miRNA study aims to identify and validate microRNAs as potential blood-based biomarkers for assessing treatment response in locally advanced rectal cancer. This could address a significant unmet need in the oncology market, where current biomarkers (CEA and ctDNA) have limitations. If successful, the findings could lead to enhanced patient stratification and monitoring, potentially improving treatment outcomes and reducing healthcare costs. The study's focus on non-invasive liquid biopsies aligns with the growing trend towards personalized medicine and could position the sponsor favorably in the competitive landscape of cancer diagnostics.

Matched by modality_normalized: RNA therapy

Protective Gr1low Monocytes and Macrophages in Compensated Cardiac Hypertrophy to Limit Decompensation and Heart Damaging

The PROMOMA trial, sponsored by Assistance Publique - Hôpitaux de Paris, aims to elucidate the protective role of Gr1low monocytes and macrophages in patients with compensated cardiac hypertrophy. Given the increasing prevalence of heart failure and its associated healthcare costs, successful outcomes could lead to novel therapeutic strategies that may significantly impact the heart failure market. The trial's focus on identifying specific biomarkers for compensated cardiac hypertrophy may position the sponsor favorably in the competitive landscape, particularly if these biomarkers can be translated into diagnostic or therapeutic products. The anticipated completion date in April 2024 suggests a timeline for potential data readouts that could inform future development pathways and partnerships.

Matched by modality_normalized: RNA therapy

A Phase 1, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of mRNA-6231, Encoding for a Human Serum Albumin - Interleukin-2 Mutein Fusion Protein (HSA-IL2m), in Healthy Adults

ModernaTX, Inc. is advancing mRNA-6231, an innovative therapeutic candidate targeting the immune modulation space through a novel fusion protein approach. The Phase 1 trial, which has been completed, aims to establish safety and tolerability profiles for escalating doses of mRNA-6231 in healthy adults. Given the growing interest in mRNA-based therapies, particularly in oncology and autoimmune diseases, successful outcomes could position Moderna favorably against competitors in the immunotherapy landscape. The trial's completion and subsequent data analysis will be critical for informing potential partnerships or further development strategies, especially in light of the increasing demand for effective immunomodulatory agents.

Matched by modality_normalized: RNA therapy

Effects of Supervised Exercise During Gestation on Maternal and Foetal Health Markers. The GESTAFIT Project

The GESTAFIT Project, sponsored by Universidad de Granada, investigates the impact of supervised exercise on maternal and fetal health in overweight pregnant women. Given the rising prevalence of obesity and associated pregnancy complications, this study addresses a significant public health concern. The findings could inform clinical guidelines and interventions aimed at improving maternal and neonatal outcomes, potentially leading to market opportunities in maternal health products and services. The results may also enhance the competitive positioning of stakeholders involved in prenatal care and obesity management. Companies focusing on maternal health, exercise programs, and nutritional supplements may find strategic partnerships or product development opportunities arising from this research.

Matched by modality_normalized: RNA therapy

Analyse Des Sillons Corticaux Par IRM morphométrique : développement de Biomarqueurs neurodéveloppementaux Des Troubles Bipolaires

The study, sponsored by Assistance Publique Hopitaux De Marseille, aims to develop neurodevelopmental biomarkers for bipolar disorder through morphometric MRI analysis of cortical sulci. This research addresses the phenotypic heterogeneity of bipolar disorder, potentially leading to improved patient stratification and targeted therapies. The market for bipolar disorder treatments is significant, with ongoing demand for innovative diagnostic and therapeutic solutions. The findings could enhance the understanding of bipolar disorder's neurodevelopmental aspects, positioning the sponsor favorably in the competitive landscape of psychiatric research. Diligence considerations include the study's ability to recruit participants effectively and the potential for collaboration with pharmaceutical companies interested in biomarker development.

Matched by modality_normalized: RNA therapy

A Clinical Study to Investigate Safety, Tolerability, and Preliminary Efficacy of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases

The clinical trial for ABO2203, an mRNA encoding CD19/CD3 T cell engager, is sponsored by Ruijin Hospital and aims to address refractory autoimmune diseases, a significant unmet medical need. The trial's focus on patients who have shown inadequate responses to standard of care (SoC) positions it strategically within a competitive landscape that includes existing biologics and emerging therapies targeting autoimmune conditions. The potential for a novel mRNA-based therapy could provide a competitive edge, especially if preliminary efficacy results are favorable. The estimated timeline for primary completion in November 2027 suggests a pathway for potential market entry by 2028, contingent upon successful outcomes and regulatory approvals.

Matched by modality_normalized: RNA therapy

Limited Adipose Tissue Expandability as a Risk Factor for Development of Type 2 Diabetes: the Role of Preadipocytes

The LIMEX study, sponsored by Charles University, investigates the role of preadipocytes in adipose tissue expandability and its implications for type 2 diabetes (T2DM) risk. Given the rising prevalence of T2DM globally, understanding the genetic and metabolic factors influencing adipose tissue behavior could lead to novel therapeutic strategies. The findings may inform the development of targeted interventions or drugs aimed at enhancing adipogenic capacity and improving insulin sensitivity, potentially capturing a significant share of the diabetes management market. The competitive landscape includes existing diabetes therapies and emerging treatments focusing on metabolic health, necessitating thorough diligence on potential partnerships or licensing opportunities.

Matched by modality_normalized: RNA therapy

Study of Personalized Alpha tACS for the Recovery of Disorders of Consciousness : Controlled Evaluation With a Single Case Experimental Design

The SPARC trial, sponsored by Hospices Civils de Lyon, aims to evaluate the efficacy of personalized alpha transcranial alternating current stimulation (tACS) in patients with disorders of consciousness following traumatic brain injury. Given the limited therapeutic options currently available for DoC, this study addresses a significant unmet medical need. If successful, the findings could pave the way for novel non-invasive treatment modalities, potentially capturing a share of the neurorehabilitation market, which is increasingly focused on innovative neuromodulation techniques. The trial's design, utilizing a Single-Case Experimental Design (SCED), enhances the sensitivity of results, which may attract interest from pharmaceutical companies and investors looking to expand their portfolios in neuromodulation therapies. However, the small sample size may limit initial commercial viability until further confirmatory studies are conducted.

A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Serum Virus Neutralizing Antibody Responses, and Pharmacokinetics of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Invivyd, Inc. is advancing VYD2311, a COVID-19 vaccine, through a Phase 3 clinical trial aimed at evaluating its safety, tolerability, and immunogenicity compared to existing COVID-19 vaccines. The trial's design includes a randomized, double-blind methodology with a focus on both standalone and coadministration scenarios with a COVID-19 vaccine. Given the ongoing global demand for effective COVID-19 vaccines, successful outcomes could position VYD2311 favorably in a competitive market, particularly against established players. The trial is currently recruiting participants, with an estimated completion date in August 2026, indicating a strategic timeline for potential market entry. The results could have significant implications for public health and pandemic management, especially in addressing emerging variants of SARS-CoV-2.

Matched by modality_normalized: RNA therapy

Muscle Isometric Contraction for the Treatment of Knee Osteoarthritis

The study sponsored by Chengdu Sport University aims to explore the efficacy of varying intensities of Muscle Isometric Contraction (MIC) in treating symptoms of Knee Osteoarthritis (KOA) among elderly women. Given the increasing prevalence of KOA in aging populations, this intervention could address a significant unmet medical need. The potential for non-pharmacological treatment options may appeal to healthcare providers and patients seeking alternatives to traditional pain management strategies. The competitive landscape includes existing physical therapy modalities and pharmacological treatments, necessitating a thorough diligence process to assess market entry strategies and potential partnerships.

Matched by modality_normalized: RNA therapy

Modulation of Small Intestinal Microbial Composition and Activity,Systemic Immune Adaptation and Blood Transcriptional Changes Induced by 2-wks Consumption With 2 Fermented Milk Products;a Randomized,Exploratory,Cross-over,Double Blind,Controlled Study in Ileostomy Patients

This study, sponsored by Maastricht University Medical Center, investigates the effects of two fermented milk products on the small intestinal microbiota and related immune and metabolic responses in ileostomy patients. The findings could have significant implications for the development of dietary interventions aimed at enhancing gut health, particularly in patients with altered gastrointestinal function. The market for probiotics and functional foods is expanding, with increasing consumer interest in gut health. Successful outcomes may position the sponsor favorably against competitors in the probiotic sector, especially if the results demonstrate clear benefits in microbiota modulation and immune system enhancement. Diligence should focus on the scalability of the interventions and potential regulatory pathways for commercialization.

Spontaneous Coronary Artery Dissection - Antiplatelet Therapy Intensity in Guided Conservative Management (SCAD-ALIGN) Trial

The SCAD-ALIGN trial, sponsored by Universitätsklinikum Hamburg-Eppendorf, aims to establish optimal antiplatelet therapy strategies for patients with spontaneous coronary artery dissection (SCAD), a condition predominantly affecting younger women. This trial is significant as it addresses a gap in current treatment protocols, which often apply general acute coronary syndrome guidelines that may not be suitable for SCAD patients. The results could lead to a paradigm shift in SCAD management, potentially influencing clinical guidelines and creating a new standard of care. Given the rarity of SCAD, successful outcomes may enhance the sponsor's reputation in cardiovascular research and open avenues for partnerships with other institutions and pharmaceutical companies interested in cardiovascular therapies. The market for antiplatelet therapies is substantial, and demonstrating the efficacy of a moderate treatment strategy could lead to a competitive advantage in this segment.

Role of IMP3 Expression in Colorectal Carcinoma: An Immunohistochemical Study

The study investigates the role of IMP3 as a prognostic marker in colorectal carcinoma (CRC), a significant health concern in Egypt with a notable male predominance. The findings could position IMP3 as a valuable biomarker for CRC, potentially leading to the development of targeted therapies or diagnostic tools. Given the high incidence of CRC in developing countries, there is a substantial market opportunity for products that enhance early detection and treatment outcomes. Competitive analysis should consider existing biomarkers and therapeutic agents targeting similar pathways. Diligence should focus on the regulatory landscape for biomarkers in oncology and potential collaborations with local healthcare providers.

Matched by modality_normalized: RNA therapy

MEDECA - Markers in Early Detection of Cancer

The MEDECA study, sponsored by Danderyd Hospital, aims to develop a multi-analyte blood test for the early detection of cancer in patients presenting with non-specific symptoms. Given the increasing demand for early cancer diagnostics, this study addresses a significant unmet need in oncology. The potential for a successful diagnostic test could position Danderyd Hospital as a leader in cancer diagnostics, attracting partnerships with pharmaceutical companies and diagnostic firms. The market for cancer diagnostics is projected to grow substantially, driven by advancements in biomarker discovery and machine learning applications. Competitive implications include the need to monitor similar studies and technologies in development by other institutions and companies focusing on early cancer detection.

Matched by modality_normalized: RNA therapy

Characterization of Bone Marrow Adipocytes in Osteoarthritic and Post-menopausal Patients: a Comparative Study With Adipocytes From Subcutaneous Adipose Tissue

The study, sponsored by University Hospital, Lille, aims to elucidate the role of bone marrow adipocytes in osteoarthritis, particularly in post-menopausal women. Given the increasing prevalence of osteoarthritis, especially among aging populations, this research could lead to novel therapeutic strategies targeting adipocyte-mediated pathways. The findings may enhance the understanding of obesity's impact on joint health, potentially opening avenues for new treatments and interventions in the osteoarthritis market. Companies focusing on metabolic disorders and joint health may find strategic partnerships or investment opportunities arising from this research. The competitive landscape includes existing therapies for osteoarthritis, but this study may provide insights that could differentiate future products based on adipocyte modulation.

Matched by modality_normalized: RNA therapy

Immune Response Dynamics Predicted by Genomic Patterns in Head and Neck Cancer (HNSCC): a Translational Research Study of the Hellenic Cooperative Oncology Group

The NCR-17-12885 project addresses a significant unmet need in the treatment of locally advanced and recurrent/metastatic HNSCC by integrating genomic and immune response data to optimize therapeutic interventions. The focus on immune checkpoint inhibitors positions this study within a rapidly evolving market, particularly as the demand for personalized medicine increases. The results may enhance the competitive landscape by providing a novel immuno-genomics test that could lead to improved patient stratification and treatment outcomes. Companies involved in HNSCC therapies and diagnostics should monitor the findings closely for potential collaborations or competitive threats.

Matched by modality_normalized: RNA therapy

The Effects of a Nature-Based Mindfulness-Compassion Intervention for Older Adults Delivered Using Virtual Reality: A Randomized Controlled Trial

The randomized controlled trial (RCT) conducted by McGill University investigates the feasibility and effectiveness of a virtual reality (VR) meditation program, 'Toujours Dimanche', aimed at improving mental health and well-being in older adults. Given the aging global population, there is a growing market for innovative mental health interventions tailored to this demographic. The integration of VR technology in mental health care represents a competitive advantage, particularly as traditional methods may not engage older adults effectively. The results of this pilot study could pave the way for larger-scale trials and potential commercialization of the VR application, especially if positive outcomes are demonstrated. Collaborations with not-for-profit organizations like Super Sublime may enhance community engagement and funding opportunities.

Matched by modality_normalized: RNA therapy

The Impact of Plant Sterols on the Dietary Cholesterol-Induced Expression of GPR146: A Randomized Double-Blind Cross-Over Study

This study, sponsored by Maastricht University Medical Center, aims to elucidate the role of plant sterols in modulating the expression of the GPR146 gene, which is implicated in cholesterol metabolism. The findings could have significant implications for dietary interventions targeting cholesterol management, potentially leading to new dietary supplements or therapeutic strategies. The market for cholesterol-lowering products is substantial, with increasing consumer awareness around cardiovascular health. Competitive analysis should focus on existing cholesterol management products and dietary supplements, particularly those leveraging plant-based ingredients. Diligence should assess the regulatory landscape for dietary supplements and any potential claims that could arise from the study's outcomes.

Matched by modality_normalized: RNA therapy

Clinical Application Research and Evaluation of Biomarkers Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

This observational study, sponsored by Nanjing First Hospital, aims to identify biomarkers that predict clopidogrel resistance in ischemic stroke patients. The potential commercial implications are significant, as clopidogrel is widely used for secondary stroke prevention. If successful, the study could lead to the development of a biomarker panel that enhances patient stratification and treatment efficacy, thereby improving clinical outcomes and reducing healthcare costs. The market for stroke management and antiplatelet therapies is substantial, with ongoing competition from emerging therapies and diagnostics. Companies focusing on personalized medicine and biomarker development may find strategic partnerships or acquisition opportunities in this space.

Matched by modality_normalized: RNA therapy

Influences on and Prevention of Self-harm Behaviour Among the Most At-risk Adolescents

The study, sponsored by the University of Ljubljana, aims to develop a robust methodology for identifying adolescents at risk of self-harm and to create guidelines for effective treatment. Given the rising incidence of mental health issues among adolescents, particularly self-harm and suicidality, this research addresses a critical gap in mental health care. The findings could lead to the development of targeted interventions and potentially inform new therapeutic approaches, positioning the sponsor as a leader in adolescent mental health research. The market for mental health solutions is expanding, with increasing demand for evidence-based treatments, suggesting significant commercial potential for any resulting methodologies or interventions.

Matched by modality_normalized: RNA therapy

Effect of Alexander Technique on Neck Pain and Quality of Life in Lactating Women

The clinical trial, sponsored by Cairo University, aims to assess the effectiveness of the Alexander Technique in alleviating neck pain and improving quality of life among lactating women. This demographic is often underserved in terms of targeted therapeutic interventions for postpartum conditions. The study's findings could position the Alexander Technique as a viable non-pharmacological treatment option, potentially opening avenues for integration into maternal health programs. Given the increasing focus on holistic and non-invasive therapies in women's health, successful outcomes could enhance market interest and adoption. However, the competitive landscape includes conventional therapies such as TENS and moist heat, which are already established in clinical practice. Stakeholders should monitor the trial's progress and outcomes closely to evaluate the commercial viability of the Alexander Technique in this context.

Matched by modality_normalized: RNA therapy

A Phase I/IIa (Multi-center, Open-label, Phase I and Multi-center, Open-label, Phase IIa ) Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

EyeGene Inc.'s EG-COVID and EG-COVARo vaccines are positioned within the competitive landscape of COVID-19 vaccine development, focusing on safety, tolerability, and immunogenicity in healthy adults. Given the ongoing global demand for effective COVID-19 vaccines, particularly with emerging variants, successful outcomes could enhance EyeGene's market presence and potential partnerships. The study's completion in early 2025 may align with ongoing vaccination campaigns, providing a strategic entry point into the market. However, the competitive landscape remains robust, with established players and new entrants continually innovating, necessitating vigilance in market positioning and differentiation strategies.

Matched by modality_normalized: RNA therapy

Immunomodulatory Role of Eosinophils in Determining Inflammation and Insulin Sensitivity in Human Adipose Tissue- Aims 1&2

The study conducted by Mayo Clinic investigates the immunomodulatory role of eosinophils in adipose tissue, particularly focusing on their relationship with inflammation and insulin sensitivity. Given the rising prevalence of obesity and insulin resistance globally, this research could have significant implications for developing therapeutic strategies targeting eosinophils to improve metabolic health. The findings may enhance the understanding of obesity-related inflammation and lead to potential dietary supplement interventions, such as fish oil, which could be marketed to consumers seeking to manage weight and metabolic health. The competitive landscape includes other obesity and insulin resistance therapies, but the unique focus on eosinophils may provide a novel angle for differentiation. Diligence should assess the potential for commercialization based on the study's outcomes and the regulatory pathway for any resultant products.

Matched by modality_normalized: RNA therapy

Network-based Epigenome-Wide associaTion Study in Obesity precisioN Medicine: NEWTON Clinical Trial

The NEWTON Clinical Trial, sponsored by the University of Campania Luigi Vanvitelli, aims to explore the epigenetic underpinnings of obesity and its complications through Next Generation Sequencing (NGS). Given the rising global obesity epidemic, which affects over 650 million individuals, this study addresses a significant unmet medical need. The identification of subgroups of obesity patients who may respond differently to treatments could enhance personalized medicine approaches, potentially leading to the development of targeted therapies. The findings may provide valuable insights for pharmaceutical companies focusing on obesity and metabolic disorders, as well as for those developing diagnostic tools based on epigenetic biomarkers. The competitive landscape includes other obesity-related studies, but the unique focus on epigenetics and network-based algorithms may differentiate this trial. Diligence should consider the regulatory landscape for epigenetic therapies and the potential for partnerships with biotech firms specializing in genomics and personalized medicine.

Molecular Mechanisms Underlying Hip and Knee Osteoarthritis in Patients Undergoing Primary Elective Arthroplasty

This observational study, sponsored by the Medical University of Warsaw, aims to elucidate the role of rare metals and trace elements in the pathophysiology of hip and knee osteoarthritis. The findings could lead to novel therapeutic strategies, such as supplementation or immunomodulation, enhancing treatment options for osteoarthritis patients. Given the increasing prevalence of osteoarthritis and the growing market for joint health therapies, successful outcomes may position the sponsor favorably within a competitive landscape that includes both pharmaceutical and nutraceutical interventions. The study's focus on biochemical and immunological parameters may also attract interest from companies involved in biomarker development and personalized medicine.

Matched by modality_normalized: RNA therapy

Effect of the Mushroom Extract Andosan on Symptoms and Inflammatory Parameters in Patients With Rheumatoid Arthritis (RA)

The clinical trial investigating AndoSan, a mushroom extract, for the treatment of rheumatoid arthritis (RA) addresses a significant unmet need in a market characterized by limited efficacy of existing therapies and high patient demand for alternative treatments. With RA affecting approximately 0.4-0.5% of the population in Norway and higher incidence rates in women, the potential for AndoSan to provide a novel therapeutic option could position it favorably in the competitive landscape. The trial's completion suggests readiness for further development, possibly leading to expanded clinical trials or partnerships with larger pharmaceutical entities. The results could enhance the marketability of AndoSan, particularly if they demonstrate significant improvements in symptom management and quality of life for RA patients.

Matched by modality_normalized: RNA therapy